Old chestnuts aren’t allowed to settle.
Unbalanced pharmacy media reporting just keeps on keeping on.
I was puzzled recently about a debate around the value of homeopathy in the UK.
The report keeps the pot boiling on how homeopathic remedies are a “waste of money” and more importantly, “may even cause harm”.
More fascinating to me was the same amount of space in this Australian pharmacy publication allocated to these following issues:
Combined administration of antidepressants and non-steroidal anti-inflammatories are associated with an increased risk of intracranial haemorrhage within thirty days of initial combination.
Liver toxicity with paracetamol “danger” (their word, not mine) where one in five paracetamol-related liver injuries reported to Canada Vigilance mentioned doses within the recommended range of less than 4G a day.
High school students in China (might it be happening here?) use pain relievers as the most abused prescription drugs, followed by stimulants, tranquillizers and sedatives.
I therefore pose the following questions:
Why are there not the same levels of patient concern in these three aspects of health where each of us might be very closely involved?
Where are our public expressions of drug safety in the pharmacy media with respect to these issues? The comments? The “Letters to the Editor” reassuring Australians that we are the responsible health practitioners to monitor this stuff?
Why did we get so publicly hysterical about the homeopathic debate when this “may even cause harm” statement can’t be substantiated? Were professional issues the fault of the modality, or the fault of the practitioner?
These four aspects of health were reported on the one day.
I wonder where our priorities actually lie.